Parnian Alavi

Ms. Parnian Alavi

University of Alberta
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Atherosclerosis
Verified
Journal Article
Closed access
AMAnahita Mojiri
Anahita Mojiri
PAParnian Alavi
Parnian Alavi
MCMaria Areli Lorenzana Carrillo
Maria Areli Lorenzana Carrillo
MNMaryam Nakhaei-Nejad
Maryam Nakhaei-Nejad
Consolato SergiConsolato Sergi
Consolato Sergi
NJNadia Jahroudi
Nadia Jahroudi

14 April 2013 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
PAParnian Alavi
Parnian Alavi
RYReza Yousefi
Reza Yousefi
SASara Amirghofran
Sara Amirghofran
HKHamid Reza Karbalaei-Heidari
Hamid Reza Karbalaei-Heidari
AMAli Akbar Moosavi-Movahedi
Ali Akbar Moosavi-Movahedi

16 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PAParnian Alavi
Parnian Alavi
ARAbhisha M Rathod
Abhisha M Rathod
NJNadia Jahroudi
Nadia Jahroudi
Endothelial cells that cover the lumen of all blood vessels have the inherent capacity to express both pro and anticoagulant molecules. However, under normal physiological condition, they generally function to maintain a non-thrombogenic surface for unobstructed blood flow. In response to injury, certain stimuli, or as a result of dysfunction, endothelial cells release a highly adhesive procoagulant protein, von Willebrand factor (VWF), which plays a central role in formation of platelet aggregates and thrombus generation. Since VWF expression is highly restricted to endothelial cells, regulation of its levels is among the most important functions of endothelial cells for maintaining hemostasis. However, with aging, there is a significant increase in VWF levels, which is concomitant with a significant rise in thrombotic events. It is not yet clear why and how aging results in increased VWF levels. In this review, we have aimed to discuss the age-related increase in VWF, its potential mechanisms, and associated coagulopathies as probable consequences.

1 January 2014
Verified
Journal Article
Open access
ZAZahra Amidzadeh
Zahra Amidzadeh
ABAbbas Behzad-Behbahani
Abbas Behzad-Behbahani
NENasrolla Erfani
Nasrolla Erfani
SSSedigheh Sharifzadeh
Sedigheh Sharifzadeh
RRReza Ranjbaran
Reza Ranjbaran
NANegar Azarpira
Negar Azarpira
Various fixation and permeabilization techniques have been developed for detection of intracellular antigens by flow cytometry; however, there are few studies using flow cytometry to detect the frequency of intracellular nucleic acids, particularly RNA. We tested six different permeabilization methods in order to gain access to a high quality method with minimal damage to intracellular components focusing on 18S rRNA in HeLa cells. HeLa cells were fixed in 2% paraformaldehyde. A variety of detergents and enzymes including saponin, TritonX-100, Tween-20, NP40, Proteinase K, and streptolysin O were used to optimize a protocol of permeabilization for the flow cytometric enumeration of intracellular 18S rRNA. Treated cells were subjected to standard protocol of flow cytometric in situ hybridization in the presence of FITC-labeled sense and antisense probes to detect 18S ribosomal RNAs. Samples were then analyzed on a FACSCalibur flow cytometer. To evaluate cell morphology, following hybridization the cells were fixed on glass slide, covered with DAPI, and evaluated on a fluorescent microscope with appropriate filter sets. In comparison with other methods, maximum cell frequency in percentage and fluorescent intensity (M1 = 2.1%, M2 = 97.9%) were obtained when the cells were treated with 0.2% Tween-20 and incubated for 30 min (p = 0.001). Our study indicated that the highest levels of mean fluorescence could be obtained when the cells were treated with Tween-20. However, it should be taken into consideration that for a successful flow cytometric result, other interfering factors such as hybridization conditions should also be optimized.

1 October 2012 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
RYReza Yousefi
Reza Yousefi
SJShima Jalili
Shima Jalili
PAParnian Alavi
Parnian Alavi
AMAli-Akbar Moosavi-Movahedi
Ali-Akbar Moosavi-Movahedi

18 May 2016 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
RPRahil Parsa
Rahil Parsa
SASetare Adibzadeh
Setare Adibzadeh
ABAbbas Behzad Behbahani
Abbas Behzad Behbahani
AFAli Farhadi
Ali Farhadi
RYRamin Yaghobi
Ramin Yaghobi
PAParnian Alavi
Parnian Alavi
Background: Infection with hepatitis E virus (HEV) is endemic in developing countries and reveals significant regional differences. Several studies have reported virus transmission via blood transfusion. To date, however, no cases of HEV RNA detection in blood donors have been reported from Iran. Objectives: The aim of this study was to determine the presence of HEV RNA in plasma samples of blood donors referred to a blood transfusion center in Shiraz in the southwest of Iran. The HEV genotypes were also investigated using nucleotide sequencing. Patients and Methods: Blood samples were collected from 700 blood donors who were referred to Fars blood transfusion organization from January to March 2014. Plasma samples were screened for the presence of HEV IgG and IgM antibodies by standard enzyme immunoassay. Samples seroreactive to anti-HEV were further tested for the presence of HEV RNA using nested polymerase chain reaction (PCR) with universal primers for detection of all four HEV genotypes. Positive PCR samples were then subjected to DNA sequencing for further analysis. Results: Fifty (50, 7.1%) out of 700 plasma samples tested positive for anti-HEV antibodies. HEV RNA was detected in 7/50 (12%) of the antibody-positive samples, the majority of which were IgM positive. Sequence analysis of seven isolates of the HEV RNA ORF 2 gene region revealed > 80% similarity with genotype 1. Conclusions: The analysis indicates that the HEV isolated from blood donors in the southwest of Iran belongs to genotype 1. However, more samples from other geographic regions of Iran are needed to confirm these findings. Because transmission of HEV by administration of blood or blood components is likely to occur, it may be sensible to screen donor blood for HEV to eliminate transfusion-transmitted HEV infection when the recipient is immunocompromised. Keywords: Blood Donors; Genotype; Hepatitis E Virus; Iran